1. Home
  2. NDLS vs NVNO Comparison

NDLS vs NVNO Comparison

Compare NDLS & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noodles & Company

NDLS

Noodles & Company

HOLD

Current Price

$0.73

Market Cap

29.8M

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$0.33

Market Cap

16.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NDLS
NVNO
Founded
1995
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.8M
16.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
NDLS
NVNO
Price
$0.73
$0.33
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
625.1K
956.3K
Earning Date
11-05-2025
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$494,087,000.00
N/A
Revenue This Year
$2.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.30
52 Week High
$1.74
$5.62

Technical Indicators

Market Signals
Indicator
NDLS
NVNO
Relative Strength Index (RSI) 47.91 31.90
Support Level $0.76 $0.32
Resistance Level $1.08 $0.37
Average True Range (ATR) 0.10 0.04
MACD -0.00 0.01
Stochastic Oscillator 31.37 6.24

Price Performance

Historical Comparison
NDLS
NVNO

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: